暂无分享,去创建一个
Puneet Singla | Kuldeep Singh | Chetan Nichkawde | Ketan Sarode | Anurag Chandrakar | P. Singla | Kuldeep Singh | K. Sarode | A. Chandrakar | Chetan Nichkawde
[1] Kyle Lo,et al. The COVID-19 Open Research Dataset - Abstract , 2020, SIIRH@ECIR.
[2] R. Albrecht,et al. SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems , 2020, bioRxiv.
[3] Leo Katz,et al. A new status index derived from sociometric analysis , 1953 .
[4] Kwok-Hung Chan,et al. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial , 2020, The Lancet.
[5] E. Bouřa,et al. Adenosine triphosphate analogs can efficiently inhibit the Zika virus RNA-dependent RNA polymerase. , 2017, Antiviral research.
[6] S. Sriramula,et al. Excessive Glutamate Stimulation Impairs ACE2 Activity Through ADAM17-Mediated Shedding in Cultured Cortical Neurons , 2018, Cellular and Molecular Neurobiology.
[7] D. Smee,et al. The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses , 2016, Journal of Virology.
[8] H. Naim,et al. Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus , 2020, Emerging microbes & infections.
[9] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[10] S. Shalhoub. Interferon beta-1b for COVID-19 , 2020, The Lancet.
[11] Z. Memish,et al. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial , 2018, Trials.
[12] C. Rice,et al. LY6E impairs coronavirus fusion and confers immune control of viral disease , 2020, Nature Microbiology.
[13] Lukasz Kaiser,et al. Attention is All you Need , 2017, NIPS.
[14] H. Zeng,et al. LY6E Restricts the Entry of Human Coronaviruses, including the currently pandemic SARS-CoV-2 , 2020, bioRxiv.
[15] Yung-Hsien Chang,et al. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction , 2005, Antiviral Research.
[16] Oren Etzioni,et al. CORD-19: The Covid-19 Open Research Dataset , 2020, NLPCOVID19.
[17] Tin-Yun Ho,et al. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction , 2006, Antiviral Research.